Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to find out if there is any association between a mother's exposure to bacteria that normally causes "strep throat" and her baby's developing heart disease/heart defect.


Clinical Trial Description

The primary objective of this study is to:

1. measure maternal ß-hemolytic streptococcal carriage as defined by positive throat cultures in the absence of symptoms among Hypoplastic Left Heart Syndrome (HLHS) mothers.

2. define the incidence of positive strep throat cultures among asymptomatic pregnant women, identified at <18 weeks gestation and followed to term.

3. Measure antibodies that may cross react to select valvular/myocardial antigens in HLHS/Congenital Heart Defect(CHD)-other neonates born to mothers in the study

4. determine serum and/or tissue reactivity against antibodies in matched maternal serum.

The secondary objectives of this study is to:

1. measure maternal ß-hemolytic streptococcal serology using standard serology testing among HLHS mothers.

2. determine the history of maternal ß-hemolytic streptococcal exposure using a study questionnaire among HLHS mothers.

3. Determine "baseline" strep serologies and history of strep exposure among a cohort of asymptomatic pregnant women, identified at <18 weeks gestation and followed to term.

The overall purpose of this study is to evaluate the history of β-hemolytic streptococcal pharyngeal exposure, groups A, G and C ("strep throat") in pregnant women whose pregnancies have been complicated by the diagnosis of congenital heart disease. Our short-term goal is to identify a potential association of an antecedent maternal strep throat exposure in pregnancy to identify a subset of heart defects

4. To determine if co-infections play a role in congenital heart defects ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01603732
Study type Observational
Source Washington University School of Medicine
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date December 2015

See also
  Status Clinical Trial Phase
Terminated NCT03616730 - NICOM in Pregnant Women With Heart Disease
Completed NCT03737006 - Coxsackie Virus in Pregnancy and Congenital Heart Disease
Not yet recruiting NCT04382222 - Prenatal Screening for Congenital Heart Diseases in the Antwerp Region
Not yet recruiting NCT05940363 - The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China